These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18828233)

  • 1. Challenge of coadministering antiretroviral therapy and oral anticoagulants in HIV-positive patients.
    Goldstein KM; Gluckman S; Mounzer K
    AIDS Read; 2008 Sep; 18(9):480-2, 486-9. PubMed ID: 18828233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis.
    Andrade RA; Evans RT; Hamill RJ; Zerai T; Giordano TP
    Ann Pharmacother; 2009 May; 43(5):908-13. PubMed ID: 19401476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy for HIV-infected people in Papua New Guinea: challenges and opportunities.
    McBride WJ; Bradford D
    P N G Med J; 2004; 47(1-2):22-30. PubMed ID: 16496512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient oral anticoagulant management--an audit of 82 patients.
    Kakkar N; Kaur R; John M
    J Assoc Physicians India; 2005 Oct; 53():847-52. PubMed ID: 16459526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiretroviral therapy in critically ill patients: a French national study].
    Dinh A; Salomon J; Vuagnat A; De Truchis P; Maury E; Bernard L
    Med Mal Infect; 2007 Dec; 37(12):809-15. PubMed ID: 17628372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of HIV positive pregnancies in Ontario: current status.
    Gahir S; Anger GJ; Ibrahim M; Read S; Piquette-Miller M
    Can J Clin Pharmacol; 2009; 16(1):e68-77. PubMed ID: 19151422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
    Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
    Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa.
    McInerney PA; Ncama BP; Wantland D; Bhengu BR; McGibbon C; Davis SM; Corless IB; Nicholas PK
    Nurs Health Sci; 2008 Dec; 10(4):266-72. PubMed ID: 19128302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
    Justesen US
    Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.
    MacDonald L; Murty M; Foster BC
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):563-78. PubMed ID: 19442034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-antiretroviral interactions.
    Liedtke MD; Rathbun RC
    Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
    Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH
    Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical safety of a generic fixed-dose combination of stavudine/lamivudine/névirapine (Triomune). Study of 297 cases in Togo].
    Mouhari-Touré A; Saka B; Kombat K; Tchangaï-Walla K; Pitche P
    Bull Soc Pathol Exot; 2008 Dec; 101(5):404-6. PubMed ID: 19192611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favourable use of non-boosted fosamprenavir in patients treated with warfarin.
    Honda H; Gatanaga H; Matsumura J; Kamimura M; Goto K; Tsukada K; Honda M; Teruya K; Kikuchi Y; Oka S
    Int J STD AIDS; 2009 Jun; 20(6):441. PubMed ID: 19451340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.